Report Detail
Global Lower Back Pain Drug Market Growth (Status and Outlook) 2022-2028
- RnM4445343 |
- 30 May, 2022 |
- Global |
- 104 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
As the global economy mends, the 2021 growth of Lower Back Pain Drug will have significant change from previous year. According to our (LP Information) latest study, the global Lower Back Pain Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Lower Back Pain Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Lower Back Pain Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Lower Back Pain Drug market, reaching US$ million by the year 2028. As for the Europe Lower Back Pain Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Lower Back Pain Drug players cover Pfizer, Johnson and Johnson, Sanofi, and Endo Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Lower Back Pain Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Acute Drug
Chronic Drug
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Johnson and Johnson
Sanofi
Endo Pharmaceuticals
Merck
Dr. Reddy’s Laboratories
Vertebral Technologies
Medtronic
Boston Scientific
BioWave
Koninklijke Philips
Stayble Therapeutics
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Lower Back Pain Drug Market Size 2017-2028
- 2.1.2 Lower Back Pain Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Lower Back Pain Drug Segment by Type
- 2.2.1 Acute Drug
- 2.2.2 Chronic Drug
- 2.3 Lower Back Pain Drug Market Size by Type
- 2.3.1 Lower Back Pain Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Lower Back Pain Drug Market Size Market Share by Type (2017-2022)
- 2.4 Lower Back Pain Drug Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Other
- 2.5 Lower Back Pain Drug Market Size by Application
- 2.5.1 Lower Back Pain Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Lower Back Pain Drug Market Size Market Share by Application (2017-2022)
3 Lower Back Pain Drug Market Size by Player
- 3.1 Lower Back Pain Drug Market Size Market Share by Players
- 3.1.1 Global Lower Back Pain Drug Revenue by Players (2020-2022)
- 3.1.2 Global Lower Back Pain Drug Revenue Market Share by Players (2020-2022)
- 3.2 Global Lower Back Pain Drug Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Lower Back Pain Drug by Regions
- 4.1 Lower Back Pain Drug Market Size by Regions (2017-2022)
- 4.2 Americas Lower Back Pain Drug Market Size Growth (2017-2022)
- 4.3 APAC Lower Back Pain Drug Market Size Growth (2017-2022)
- 4.4 Europe Lower Back Pain Drug Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Lower Back Pain Drug Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Lower Back Pain Drug Market Size by Country (2017-2022)
- 5.2 Americas Lower Back Pain Drug Market Size by Type (2017-2022)
- 5.3 Americas Lower Back Pain Drug Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Lower Back Pain Drug Market Size by Region (2017-2022)
- 6.2 APAC Lower Back Pain Drug Market Size by Type (2017-2022)
- 6.3 APAC Lower Back Pain Drug Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Lower Back Pain Drug by Country (2017-2022)
- 7.2 Europe Lower Back Pain Drug Market Size by Type (2017-2022)
- 7.3 Europe Lower Back Pain Drug Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Lower Back Pain Drug by Region (2017-2022)
- 8.2 Middle East & Africa Lower Back Pain Drug Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Lower Back Pain Drug Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Lower Back Pain Drug Market Forecast
- 10.1 Global Lower Back Pain Drug Forecast by Regions (2023-2028)
- 10.1.1 Global Lower Back Pain Drug Forecast by Regions (2023-2028)
- 10.1.2 Americas Lower Back Pain Drug Forecast
- 10.1.3 APAC Lower Back Pain Drug Forecast
- 10.1.4 Europe Lower Back Pain Drug Forecast
- 10.1.5 Middle East & Africa Lower Back Pain Drug Forecast
- 10.2 Americas Lower Back Pain Drug Forecast by Country (2023-2028)
- 10.2.1 United States Lower Back Pain Drug Market Forecast
- 10.2.2 Canada Lower Back Pain Drug Market Forecast
- 10.2.3 Mexico Lower Back Pain Drug Market Forecast
- 10.2.4 Brazil Lower Back Pain Drug Market Forecast
- 10.3 APAC Lower Back Pain Drug Forecast by Region (2023-2028)
- 10.3.1 China Lower Back Pain Drug Market Forecast
- 10.3.2 Japan Lower Back Pain Drug Market Forecast
- 10.3.3 Korea Lower Back Pain Drug Market Forecast
- 10.3.4 Southeast Asia Lower Back Pain Drug Market Forecast
- 10.3.5 India Lower Back Pain Drug Market Forecast
- 10.3.6 Australia Lower Back Pain Drug Market Forecast
- 10.4 Europe Lower Back Pain Drug Forecast by Country (2023-2028)
- 10.4.1 Germany Lower Back Pain Drug Market Forecast
- 10.4.2 France Lower Back Pain Drug Market Forecast
- 10.4.3 UK Lower Back Pain Drug Market Forecast
- 10.4.4 Italy Lower Back Pain Drug Market Forecast
- 10.4.5 Russia Lower Back Pain Drug Market Forecast
- 10.5 Middle East & Africa Lower Back Pain Drug Forecast by Region (2023-2028)
- 10.5.1 Egypt Lower Back Pain Drug Market Forecast
- 10.5.2 South Africa Lower Back Pain Drug Market Forecast
- 10.5.3 Israel Lower Back Pain Drug Market Forecast
- 10.5.4 Turkey Lower Back Pain Drug Market Forecast
- 10.5.5 GCC Countries Lower Back Pain Drug Market Forecast
- 10.6 Global Lower Back Pain Drug Forecast by Type (2023-2028)
- 10.7 Global Lower Back Pain Drug Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Pfizer
- 11.1.1 Pfizer Company Information
- 11.1.2 Pfizer Lower Back Pain Drug Product Offered
- 11.1.3 Pfizer Lower Back Pain Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Pfizer Main Business Overview
- 11.1.5 Pfizer Latest Developments
- 11.2 Johnson and Johnson
- 11.2.1 Johnson and Johnson Company Information
- 11.2.2 Johnson and Johnson Lower Back Pain Drug Product Offered
- 11.2.3 Johnson and Johnson Lower Back Pain Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Johnson and Johnson Main Business Overview
- 11.2.5 Johnson and Johnson Latest Developments
- 11.3 Sanofi
- 11.3.1 Sanofi Company Information
- 11.3.2 Sanofi Lower Back Pain Drug Product Offered
- 11.3.3 Sanofi Lower Back Pain Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Sanofi Main Business Overview
- 11.3.5 Sanofi Latest Developments
- 11.4 Endo Pharmaceuticals
- 11.4.1 Endo Pharmaceuticals Company Information
- 11.4.2 Endo Pharmaceuticals Lower Back Pain Drug Product Offered
- 11.4.3 Endo Pharmaceuticals Lower Back Pain Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Endo Pharmaceuticals Main Business Overview
- 11.4.5 Endo Pharmaceuticals Latest Developments
- 11.5 Merck
- 11.5.1 Merck Company Information
- 11.5.2 Merck Lower Back Pain Drug Product Offered
- 11.5.3 Merck Lower Back Pain Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Merck Main Business Overview
- 11.5.5 Merck Latest Developments
- 11.6 Dr. Reddy’s Laboratories
- 11.6.1 Dr. Reddy’s Laboratories Company Information
- 11.6.2 Dr. Reddy’s Laboratories Lower Back Pain Drug Product Offered
- 11.6.3 Dr. Reddy’s Laboratories Lower Back Pain Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Dr. Reddy’s Laboratories Main Business Overview
- 11.6.5 Dr. Reddy’s Laboratories Latest Developments
- 11.7 Vertebral Technologies
- 11.7.1 Vertebral Technologies Company Information
- 11.7.2 Vertebral Technologies Lower Back Pain Drug Product Offered
- 11.7.3 Vertebral Technologies Lower Back Pain Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Vertebral Technologies Main Business Overview
- 11.7.5 Vertebral Technologies Latest Developments
- 11.8 Medtronic
- 11.8.1 Medtronic Company Information
- 11.8.2 Medtronic Lower Back Pain Drug Product Offered
- 11.8.3 Medtronic Lower Back Pain Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Medtronic Main Business Overview
- 11.8.5 Medtronic Latest Developments
- 11.9 Boston Scientific
- 11.9.1 Boston Scientific Company Information
- 11.9.2 Boston Scientific Lower Back Pain Drug Product Offered
- 11.9.3 Boston Scientific Lower Back Pain Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Boston Scientific Main Business Overview
- 11.9.5 Boston Scientific Latest Developments
- 11.10 BioWave
- 11.10.1 BioWave Company Information
- 11.10.2 BioWave Lower Back Pain Drug Product Offered
- 11.10.3 BioWave Lower Back Pain Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 BioWave Main Business Overview
- 11.10.5 BioWave Latest Developments
- 11.11 Koninklijke Philips
- 11.11.1 Koninklijke Philips Company Information
- 11.11.2 Koninklijke Philips Lower Back Pain Drug Product Offered
- 11.11.3 Koninklijke Philips Lower Back Pain Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Koninklijke Philips Main Business Overview
- 11.11.5 Koninklijke Philips Latest Developments
- 11.12 Stayble Therapeutics
- 11.12.1 Stayble Therapeutics Company Information
- 11.12.2 Stayble Therapeutics Lower Back Pain Drug Product Offered
- 11.12.3 Stayble Therapeutics Lower Back Pain Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Stayble Therapeutics Main Business Overview
- 11.12.5 Stayble Therapeutics Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Lower Back Pain Drug. Industry analysis & Market Report on Lower Back Pain Drug is a syndicated market report, published as Global Lower Back Pain Drug Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Lower Back Pain Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
